Status:
RECRUITING
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）
Lead Sponsor:
Zhengzhou Yuan
Conditions:
Stroke, Acute
Eligibility:
All Genders
Brief Summary
This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.
Detailed Description
IVTIS is a prospective, real-world registry lasting for 22 years. A total of 3000 patients with intravenous thrombolysis will be enrolled。
Eligibility Criteria
Inclusion
- The patient was diagnosed with acute ischemic stroke and received intravenous thrombolysis.
Exclusion
- No additional exclusion criteria.
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2046
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06131385
Start Date
November 20 2023
End Date
May 1 2046
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Southwest Medical University
Luzhou, China, 646000